Display options
Share it on

Pteridines. 2013 Aug;23(1):81-89. doi: 10.1515/pteridines.2012.23.1.81.

Use of a Pteridine Moiety to Track DNA Uptake in Cells.

Pteridines

Justin A Costa, Edgar Leal-Pinto, Scott C Henderson, Troy Zabel, Mary E Hawkins, Basil Hanss

Affiliations

  1. Division of Nephrology, Department of Medicine, Mt. Sinai School of Medicine, New York, NY.
  2. Department of Physiology and Biophysics, Virginia Commonwealth University Medical Center, Richmond, VA.
  3. Department of Anatomy and Neurobiology, Virginia Commonwealth University Medical Center, Richmond, VA.
  4. South Denver Nephrology, Denver, CO.
  5. Laboratory of Receptor Biology and Gene Expression, NCI/NIH, Bethesda, MD.

PMID: 24465092 PMCID: PMC3898856 DOI: 10.1515/pteridines.2012.23.1.81

Abstract

Fluorescence labeled oligonucleotides have a long history of being used to monitor nucleic acid transport and uptake. However, it is not known if the fluorescent moiety itself physically limits the number of pathways that can be used by the cell due to steric, hydrophobic, or other chemical characteristics. Here, we report a method for comparing the uptake kinetics of oligonucleotides labeled either with the fluorescent pteridine, 3-methyl-8-(2-deoxy-β-D-ribofuranosyl) isoxanthopterin (3MI), or the common fluorophore 5-carboxyfluorescein (5-FAM). We use a multiphoton microscopic technique to monitor nucleic acid uptake LLC-PK

Keywords: DNA uptake monitoring; fluroescence label; methylisoxathopterin

References

  1. J Exp Med. 1978 Mar 1;147(3):684-99 - PubMed
  2. J Biol Chem. 2007 Sep 21;282(38):27897-904 - PubMed
  3. Oligonucleotides. 2007 Spring;17(1):122-33 - PubMed
  4. J Membr Biol. 2008 Nov-Dec;226(1-3):1-8 - PubMed
  5. Pathology. 2007 Apr;39(2):197-207 - PubMed
  6. Nature. 2002 May 30;417(6888):555-9 - PubMed
  7. Science. 2002 Mar 29;295(5564):2456-9 - PubMed
  8. Antimicrob Agents Chemother. 1996 Jul;40(7):1670-5 - PubMed
  9. Am J Physiol. 1995 Oct;269(4 Pt 1):C1048-56 - PubMed
  10. In Vitro Cell Dev Biol. 1990 Feb;26(2):162-8 - PubMed
  11. J Pharmacol Exp Ther. 1998 Jul;286(1):447-58 - PubMed
  12. Nucleic Acids Res. 1997 Aug 15;25(16):3290-6 - PubMed
  13. J Clin Invest. 1995 Apr;95(4):1814-23 - PubMed
  14. Biol Cell. 1997 Jul;89(4):257-61 - PubMed
  15. Science. 2003 Sep 12;301(5639):1545-7 - PubMed
  16. Biochimie. 2007 Oct;89(10):1245-51 - PubMed
  17. J Cell Biol. 1963 Oct;19:71-7 - PubMed
  18. Nat Immunol. 2001 Aug;2(8):675-80 - PubMed
  19. Clin Exp Immunol. 1984 Apr;56(1):185-92 - PubMed
  20. Nature. 2000 Dec 7;408(6813):740-5 - PubMed
  21. Antisense Res Dev. 1993 Spring;3(1):53-66 - PubMed
  22. Nucleic Acids Res. 1991 Oct 25;19(20):5543-50 - PubMed
  23. Nucleic Acids Res. 1995 Aug 11;23(15):2872-80 - PubMed
  24. J Immunol. 1996 Feb 1;156(3):1151-6 - PubMed
  25. Methods Enzymol. 2008;450:201-31 - PubMed
  26. Biochem J. 1981 Sep 15;198(3):581-6 - PubMed
  27. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3156-60 - PubMed
  28. Nat Med. 1997 Apr;3(4):414-20 - PubMed
  29. Infect Immun. 1976 Oct;14(4):1011-3 - PubMed
  30. Kidney Int. 1995 May;47(5):1462-9 - PubMed
  31. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1707-12 - PubMed
  32. Anal Sci. 2001 Jan;17(1):155-60 - PubMed
  33. Pharm Res. 1992 Aug;9(8):1010-7 - PubMed
  34. Arch Dermatol Res. 1998 Mar;290(3):119-25 - PubMed
  35. Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10565-70 - PubMed
  36. J Membr Biol. 1999 May 1;169(1):13-27 - PubMed
  37. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1921-6 - PubMed

Publication Types

Grant support